- Filed
- Apr 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 26.29M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $333.71M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $348.1M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $21.84M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $24.21M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $92.68M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $87.53M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $475.78M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $484.67M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $224.27M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $220.83M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $857.85M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $858.47M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 26.2M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $10.74M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $353.68M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $349.46M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.30 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.30 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $24.89M |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.88M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $20.43M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $48.39M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $110.87M |